Published in J Bone Miner Res on April 01, 2013
The Interplay between the bone and the immune system. Clin Dev Immunol (2013) 1.26
Advances in the regulation of osteoclasts and osteoclast functions. J Dent Res (2013) 1.16
Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity. Oncoimmunology (2013) 1.06
Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases. Clin Oral Investig (2014) 0.86
Atypical femoral fracture combined with osteonecrosis of jaw during osteoporosis treatment with bisphosphonate. J Bone Metab (2014) 0.85
T-cells and B-cells in osteoporosis. Curr Opin Endocrinol Diabetes Obes (2014) 0.84
Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation. Oncotarget (2015) 0.82
Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY. J Biol Chem (2015) 0.79
Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation. J Immunother Cancer (2017) 0.77
Trauma-induced heterotopic bone formation and the role of the immune system: A review. J Trauma Acute Care Surg (2016) 0.77
Do γδ T cells predict osteonecrosis of the jaw? J Bone Miner Res (2013) 0.77
Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw. J Transl Med (2015) 0.76
Zoledronic acid causes γδ T cells to target monocytes and down-modulate inflammatory homing. Immunology (2014) 0.76
Vγ9 Vδ2 T cells may be a biomarker for ONJ risk in patients on long-term BPs. Bonekey Rep (2013) 0.75
Increased CD14+ and decreased CD14- populations of monocytes 48 h after zolendronic acid infusion in breast cancer patients. Osteoporos Int (2016) 0.75
Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization. J Musculoskelet Neuronal Interact (2017) 0.75
Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity (2004) 3.26
Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet (2010) 2.66
Aging changes of the midfacial fat compartments: a computed tomographic study. Plast Reconstr Surg (2012) 2.55
Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res (2007) 2.21
Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol (2008) 2.20
Persistent hyperinsulinemic hypoglycemia in 15 adults with diffuse nesidioblastosis: diagnostic criteria, incidence, and characterization of beta-cell changes. Am J Surg Pathol (2005) 2.04
Platelet-rich plasma and platelet-rich fibrin in human cell culture. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2009) 2.02
The effect of the WHO Surgical Safety Checklist on complication rate and communication. Dtsch Arztebl Int (2012) 1.91
Innate immunity--cross-talk with adaptive immunity through pattern recognition receptors and cytokines. Curr Opin Immunol (2006) 1.62
Activation of V gamma 9V delta 2 T cells by NKG2D. J Immunol (2005) 1.54
gammadelta T cells link innate and adaptive immune responses. Chem Immunol Allergy (2005) 1.38
Synergism between lectins and vesicles of Viscum album L.- detection by biochemical and immunological methods. J Herb Pharmacother (2002) 1.38
Direct costimulatory effect of TLR3 ligand poly(I:C) on human gamma delta T lymphocytes. J Immunol (2006) 1.38
Reconstruction of the lower lip: rationale to preserve the aesthetic units of the face. Plast Reconstr Surg (2007) 1.33
Innate immune functions of human gammadelta T cells. Immunobiology (2007) 1.32
"Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Craniomaxillofac Surg (2008) 1.29
Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence--a multi-centre study. J Craniomaxillofac Surg (2010) 1.28
Man as living bioreactor: fate of an exogenously prepared customized tissue-engineered mandible. Biomaterials (2006) 1.27
Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol (2011) 1.25
A cell-based approach to the minimization of immunosuppression in renal transplantation. Transpl Int (2008) 1.24
Inhibition of TNF receptor 1 internalization by adenovirus 14.7K as a novel immune escape mechanism. J Clin Invest (2006) 1.20
Platelet-rich fibrin membranes as scaffolds for periosteal tissue engineering. Clin Oral Implants Res (2010) 1.20
TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell Mol Life Sci (2013) 1.20
Histologic findings in sinus augmentation with autogenous bone chips versus a bovine bone substitute. Int J Oral Maxillofac Implants (2003) 1.16
Patterns of chemokine receptor expression on peripheral blood gamma delta T lymphocytes: strong expression of CCR5 is a selective feature of V delta 2/V gamma 9 gamma delta T cells. J Immunol (2002) 1.15
Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis. Int J Cancer (2014) 1.14
Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligands. J Immunol (2010) 1.13
Penicillin compared with other advanced broad spectrum antibiotics regarding antibacterial activity against oral pathogens isolated from odontogenic abscesses. J Craniomaxillofac Surg (2008) 1.10
The endoscopically controlled osteotome sinus floor elevation: a preliminary prospective study. Int J Oral Maxillofac Implants (2002) 1.10
Different properties of VEGF-antagonists: Bevacizumab but not Ranibizumab accumulates in RPE cells. Graefes Arch Clin Exp Ophthalmol (2009) 1.09
Morbidity of harvesting of retromolar bone grafts: a prospective study. Clin Oral Implants Res (2002) 1.08
Defining the nature of human γδ T cells: a biographical sketch of the highly empathetic. Cell Mol Immunol (2012) 1.07
Modulation of γδ T cell responses by TLR ligands. Cell Mol Life Sci (2011) 1.05
Toll-like receptors 3 and 7 agonists enhance tumor cell lysis by human gammadelta T cells. Cancer Res (2009) 1.04
Regulation of T cell activation by TLR ligands. Eur J Cell Biol (2011) 1.04
Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17. Int J Cancer (2013) 1.03
Prospective observation of 41 perforations of the Schneiderian membrane during sinus floor elevation. Clin Oral Implants Res (2008) 1.03
The Polycomb group protein EED couples TNF receptor 1 to neutral sphingomyelinase. Proc Natl Acad Sci U S A (2009) 1.03
gammadelta T cells in cancer immunotherapy: current status and future prospects. Immunotherapy (2009) 1.02
Histomorphometric and fluorescence microscopic analysis of bone remodelling after installation of implants using an osteotome technique. Clin Oral Implants Res (2002) 1.02
Human gamma delta T cells: candidates for the development of immunotherapeutic strategies. Immunol Res (2007) 1.01
The adaptor protein Nck interacts with Fas ligand: Guiding the death factor to the cytotoxic immunological synapse. Proc Natl Acad Sci U S A (2006) 1.01
Novel bispecific antibodies increase γδ T-cell cytotoxicity against pancreatic cancer cells. Cancer Res (2014) 1.00
Relative en- and exophthalmometry in zygomatic fractures comparing optical non-contact, non-ionizing 3D imaging to the Hertel instrument and computed tomography. J Craniomaxillofac Surg (2003) 0.99
Caspase-8 and caspase-7 sequentially mediate proteolytic activation of acid sphingomyelinase in TNF-R1 receptosomes. EMBO J (2010) 0.99
Secretory lysosomes and their cargo in T and NK cells. Immunol Lett (2006) 0.98
Expression of functional prolactin and its receptor in human colorectal cancer. Int J Colorectal Dis (2002) 0.97
HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker? Cancer Lett (2012) 0.95
Proof of direct radiogenic destruction of collagen in vitro. Strahlenther Onkol (2007) 0.95
Effects of zoledronate on irradiated bone in vivo: analysis of the collagen types I, V and their cross-links lysylpyridinoline, hydroxylysylpyridinoline and hydroxyproline. Calcif Tissue Int (2012) 0.94
Orbital floor reconstruction with resorbable polydioxanone implants. J Craniofac Surg (2012) 0.94
Novel splice variants of human IKKε negatively regulate IKKε-induced IRF3 and NF-kB activation. Eur J Immunol (2010) 0.94
When neutrophils meet T cells: beginnings of a tumultuous relationship with underappreciated potential. Eur J Immunol (2014) 0.94
The adapter protein Nck: role of individual SH3 and SH2 binding modules for protein interactions in T lymphocytes. Protein Sci (2010) 0.93
Storage, expression and function of Fas ligand, the key death factor of immune cells. Curr Med Chem (2008) 0.93
Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells. J Immunol (2003) 0.93
Vδ2 T cell deficiency in granulomatosis with polyangiitis (Wegener's granulomatosis). Clin Immunol (2013) 0.93
Quality of life in oral cancer patients--effects of mandible resection and socio-cultural aspects. J Craniomaxillofac Surg (2011) 0.93
Caspase inhibition blocks human T cell proliferation by suppressing appropriate regulation of IL-2, CD25, and cell cycle-associated proteins. J Immunol (2004) 0.92
Differential expression of CD126 and CD130 mediates different STAT-3 phosphorylation in CD4+CD25- and CD25high regulatory T cells. Int Immunol (2006) 0.92
PRP modulates expression of bone matrix proteins in vivo without long-term effects on bone formation. Bone (2005) 0.92
Ceramic scaffolds produced by computer-assisted 3D printing and sintering: characterization and biocompatibility investigations. J Biomed Mater Res B Appl Biomater (2010) 0.91
The murine TRAIL receptor signals caspase-independent cell death through ceramide. Exp Cell Res (2006) 0.90
Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies. Blood (2003) 0.90
Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells. Cell Mol Life Sci (2013) 0.90
Considering Fas ligand as a target for therapy. Expert Opin Ther Targets (2005) 0.90
Familial influences and obesity-associated metabolic risk factors contribute to the variation in resting energy expenditure: the Kiel Obesity Prevention Study. Am J Clin Nutr (2008) 0.90
Radiation caries--radiogenic destruction of dental collagen. Oral Oncol (2005) 0.90
HDR brachytherapy irradiation of the jaw - as a new experimental model of radiogenic bone damage. J Craniomaxillofac Surg (2008) 0.89
Ceramide: does it matter for T cells? Trends Immunol (2002) 0.89
Anatomic site evaluation of the zygomatic bone for dental implant placement. Clin Oral Implants Res (2003) 0.89
Tumor-induced osteomalacia: successful treatment by radio-guided tumor surgery. J Clin Rheumatol (2009) 0.89
Platform switch versus platform match in the posterior mandible – 1-year results of a multicentre randomized clinical trial. J Clin Periodontol (2014) 0.88
Endocultivation: 3D printed customized porous scaffolds for heterotopic bone induction. Oral Oncol (2009) 0.87
Interaction with XIAP prevents full caspase-3/-7 activation in proliferating human T lymphocytes. Eur J Immunol (2008) 0.87
Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells. PLoS One (2013) 0.87
The mechanical integrity of in vivo engineered heterotopic bone. Biomaterials (2005) 0.87
2-D DIGE analyses of enriched secretory lysosomes reveal heterogeneous profiles of functionally relevant proteins in leukemic and activated human NK cells. Proteomics (2008) 0.87
Bioactivation of an anorganic bone matrix by P-15 peptide for the promotion of early bone formation. Biomaterials (2005) 0.87
Identification of interaction partners of the cytosolic polyproline region of CD95 ligand (CD178). FEBS Lett (2002) 0.86
Evaluation of quality of life of patients with oral squamous cell carcinoma. Comparison of two treatment protocols in a prospective study. Radiother Oncol (2004) 0.86
Two techniques for the preparation of cell-scaffold constructs suitable for sinus augmentation: steps into clinical application. Tissue Eng (2006) 0.86
Identification of HLA-A*0201-presented T cell epitopes derived from the oncofetal antigen-immature laminin receptor protein in patients with hematological malignancies. J Immunol (2006) 0.86
Bone regeneration after topical BMP-2-gene delivery in circumferential peri-implant bone defects. Clin Oral Implants Res (2008) 0.86
Regulation of FasL expression: a SH3 domain containing protein family involved in the lysosomal association of FasL. Cell Signal (2005) 0.86
Extensive aneurysmal bone cyst of the mandible. J Craniofac Surg (2011) 0.86
The effects of magnitude and frequency of distraction forces on tissue regeneration in distraction osteogenesis of the mandible. Plast Reconstr Surg (2002) 0.86
Validation of in vivo assessment of facial soft-tissue volume changes and clinical application in midfacial distraction: a technical report. Plast Reconstr Surg (2003) 0.85
Comparison of in vitro biocompatibility of NanoBone(®) and BioOss(®) for human osteoblasts. Clin Oral Implants Res (2011) 0.85
The proteases HtrA2/Omi and UCH-L1 regulate TNF-induced necroptosis. Cell Commun Signal (2013) 0.85
Immune suppression by gammadelta T-cells as a potential regulatory mechanism after cancer vaccination with IL-12 secreting dendritic cells. J Immunother (2010) 0.85
Different substitute biomaterials as potential scaffolds in tissue engineering. Int J Oral Maxillofac Implants (2006) 0.85
Neutrophil uptake of nitrogen-bisphosphonates leads to the suppression of human peripheral blood γδ T cells. Cell Mol Life Sci (2013) 0.85
Vaccination strategy to target lysyl oxidase-like 4 in dendritic cell based immunotherapy for head and neck cancer. Int J Oncol (2008) 0.84
[Histomorphological structural changes of head and neck blood vessels after pre- or postoperative radiotherapy]. Strahlenther Onkol (2002) 0.84
Identification of interaction partners for individual SH3 domains of Fas ligand associated members of the PCH protein family in T lymphocytes. Biochim Biophys Acta (2008) 0.84
Down-regulation of the cancer/testis antigen 45 (CT45) is associated with altered tumor cell morphology, adhesion and migration. Cell Commun Signal (2013) 0.84
TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells. BMC Cancer (2014) 0.84